Showing results (2311-2320 of 5,702) with videos related to

Sort By:
Pageof 571
The Oncologist|May 4, 2019
A Phase I/II Open-Label Study of Nivolumab in Previously Treated Advanced or Recurrent Nasopharyngeal Carcinoma and Other Solid TumorsYuxiang Ma, Wenfeng Fang, Yang Zhang, et al.
The Oncologist|April 17, 2019
Addressing the Financial Burden of Cancer Clinical Trial Participation: Longitudinal Effects of an Equity InterventionRyan D Nipp, Hang Lee, Emily Gorton, et al.
The Oncologist|May 19, 2019
A Multicenter Comparison of Complementary and Alternative Medicine (CAM) Discussions in Oncology Care: The Role of Time, Patient-Centeredness, and Practice ContextJon Tilburt, Kathleen J Yost, Heinz-Josef Lenz, et al.
The Oncologist|April 26, 2019
Evaluation of the Incorporation of Recurrence Score into the American Joint Committee on Cancer Eighth Edition Staging System in Patients with T1-2N0M0, Estrogen Receptor-Positive, Human Epidermal Growth Receptor 2-Negative Invasive Breast Cancer: A Population-Based AnalysisShuning Ding, Jiayi Wu, Caijin Lin, et al.
The Oncologist|April 26, 2019
Degree of MDM2 Amplification Affects Clinical Outcomes in Dedifferentiated LiposarcomaKate Lynn J Bill, Nathan D Seligson, John L Hays, et al.
The Oncologist|April 25, 2019
Peripheral Blood Markers Identify Risk of Immune-Related Toxicity in Advanced Non-Small Cell Lung Cancer Treated with Immune-Checkpoint InhibitorsAlberto Pavan, Lorenzo Calvetti, Alessandro Dal Maso, et al.
The Oncologist|April 27, 2019
Genetic Profiling of Non-Small Cell Lung Cancer at Development of Resistance to First- or Second-Generation EGFR-TKIs by CAPP-Seq Analysis of Circulating Tumor DNAKohei Otsubo, Kazuko Sakai, Masafumi Takeshita, et al.
The Oncologist|April 27, 2019
A Pilot, Phase II, Randomized, Open-Label Clinical Trial Comparing the Neurotoxicity of Three Dose Regimens of Nab-Paclitaxel to That of Solvent-Based Paclitaxel as the First-Line Treatment for Patients with Human Epidermal Growth Factor Receptor Type 2-Negative Metastatic Breast CancerEva Ciruelos, María Apellániz-Ruiz, Blanca Cantos, et al.
The Oncologist|August 19, 2018
Prognostic Understanding at Diagnosis and Associated Factors in Patients with Advanced Lung Cancer and Their CaregiversTakashi Sato, Kenzo Soejima, Daisuke Fujisawa, et al.
The Oncologist|August 19, 2018
Adjuvant Anthracyclines in Breast Cancer: What Is Their Role?Ami N Shah, William J Gradishar
Pageof 571